Fiasp

insulin aspart · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

32 regulatory and trial events tracked for Fiasp, covering 2016-11-08 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice

See pricing